#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Drug eruption Indolent systemic mastocytosis Frostbite Systemic mastocytosis Inflammatory myofibroblastic tumour Adrenoleukodystrophy Non-renal cell carcinoma of kidney Cytokine release syndrome Ewing's sarcoma recurrent Haemophilia A without inhibitors Sarcoma Cognitive disorder Toxic epidermal necrolysis VEXAS syndrome Splenic marginal zone lymphoma More trials…

    Learn about Rare Diseases

    Lymphangiosarcoma – Diagnostics Primary biliary cholangitis – Trials in Disease Glomerulonephritis membranous – Diagnostics Langerhans’ cell histiocytosis – Treatment Ewing’s sarcoma metastatic Burkitt’s lymphoma – Trials in Disease Propionic acidaemia – Diagnostics Fabry’s disease – Diagnostics Systemic mastocytosis – Trials in Disease Osteosarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    FOSMANOGEPIX Chloropyramine Hydrochloride Insulin Glargine Divarasib Nadunolimab ICEF15 Hepatitis B Surface Antigen Haloperidol Abc-15A-116 Bempikibart Talazoparib PROMESTRIENE Lacutamab Specific Nucleic Acid Sna-Her2 MB-HUCART19.1 ULTEVURSEN M-(18F)-Fluorobenzylguanidine Cabozantinib Sirolimus Clobetasol More therapies…

    Learn about Your Condition

    Small fibre neuropathy Bile acid synthesis disorder Anorexia nervosa Glycogen storage disorder Coeliac disease Tuberculosis Colitis ulcerative Blood disorder Pulmonary embolism Lennox-Gastaut syndrome Endometrial cancer metastatic Psychological trauma Arginase deficiency Neonatal asphyxia Gaucher's disease type I More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Anxiety

  • Comparison of Oxazepam 50 mg orodispersible tablets and Oxazepam 50 mg standard tablets in healthy volunteers to test if they work the same way in the body

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Anxiety
    Investigated Drugs:
    • Oxazepam
    Portugal

  • Study on the Bioequivalence of Oxazepam 10 mg Orodispersible Tablets Compared to Standard Tablets in Healthy Volunteers

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Anxiety
    Investigated Drugs:
    • Oxazepam
    Portugal

  • Title: Evaluation of nasal remimazolam and lidocaine for sedation and anxiety in adults: Testing comfort and effectiveness of nasal spray delivery

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Anxiety
    Investigated Drugs:
    • Remimazolam
    The Netherlands

  • Study on the Effects of Yohimbine and Hydrocortisone on Stress and Moral Decisions in Military Personnel

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Anxiety
    Investigated Drugs:
    • YOHIMBINE HYDROCHLORIDE
    • Cellulose, Microcrystalline
    • Hydrocortisone
    The Netherlands

  • Study on the Effects of Sertraline on Anxiety and Depression in Heart Failure Patients with Preserved Ejection Fraction

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Anxiety
    • Depression
    • Heart failure with preserved ejection fraction
    Investigated Drugs:
    • Sertraline
    Poland

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!